Haverkamp, W <br/><br/>
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.  [electronic resource] 

 -  Cardiovascular research  Aug 2000 
 - 219-33 p.  digital 
<br/><br/> Publication Type: Congress; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-6363 
<br/><br/><label>Standard No.: </label>10.1016/s0008-6363(00)00119-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Animals<br/>Anti-Arrhythmia Agents--adverse effects<br/>Anti-Bacterial Agents--adverse effects<br/>Antipsychotic Agents--adverse effects<br/>Cardiology<br/>Clinical Trials as Topic<br/>Disease Models, Animal<br/>Drug and Narcotic Control<br/>Europe<br/>Humans<br/>Potassium Channels--drug effects<br/>Product Surveillance, Postmarketing<br/>Research<br/>Societies, Medical<br/>Torsades de Pointes--chemically induced<br/>Vasodilator Agents--adverse effects